SILVERARC CAPITAL MANAGEMENT, LLC
CIK 1816307 · Holdings on Jun 30, 2026 · First reported Aug 13, 2026
Top ten holdings
Q2 2026- ASND6.12%
- CELC5.83%
- COGT5.52%
- URGN5.33%
- IMNM4.76%
- DNTH4.23%
- RYTM3.85%
- ORKA3.74%
- GLUE2.98%
- SNDX2.95%
Share classes counted separately45.31%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- ORKAWeight increased · +2.87 pp0.87% → 3.74%Shares +201.89K (+133.79%)
- DNTHWeight decreased · -2.24 pp6.47% → 4.23%Shares -264.75K (-40.43%)
- URGNWeight increased · +2.15 pp3.18% → 5.33%Shares -201.07K (-13.38%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 25
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | ASNDASCENDIS PHARMA A/SORD SHS View history and evidence | $55.01M | 6.12% | 206.23K shares | Prior unavailable — | CUSIP change | ↗▾ |
| 02 | CELCCELCUITY INC View history and evidence | $52.41M | 5.83% | 501.00K shares | 4.81% → 5.83%+1.02 pp +143.09K (+39.98%) | Added | ↗▾ |
| 03 | COGTCOGENT BIOSCIENCES INC View history and evidence | $49.56M | 5.52% | 1.28M shares | 5.96% → 5.52%-0.44 pp -33.48K (-2.55%) | Reduced | ↗▾ |
| 04 | URGNUROGEN PHARMA LTD View history and evidence | $47.91M | 5.33% | 1.30M shares | 3.18% → 5.33%+2.15 pp -201.07K (-13.38%) | Reduced | ↗▾ |
| 05 | IMNMIMMUNOME INC View history and evidence | $42.74M | 4.76% | 2.02M shares | 4.77% → 4.76%-0.01 pp +166.73K (+9.01%) | Added | ↗▾ |
| 06 | DNTHDIANTHUS THERAPEUTICS INC View history and evidence | $38.02M | 4.23% | 390.00K shares | 6.47% → 4.23%-2.24 pp -264.75K (-40.43%) | Reduced | ↗▾ |
| 07 | RYTMRHYTHM PHARMACEUTICALS INC View history and evidence | $34.58M | 3.85% | 311.46K shares | 3.14% → 3.85%+0.71 pp +5.46K (+1.78%) | Added | ↗▾ |
| 08 | ORKAORUKA THERAPEUTICS INC View history and evidence | $33.58M | 3.74% | 352.80K shares | 0.87% → 3.74%+2.87 pp +201.89K (+133.79%) | Added | ↗▾ |
| 09 | GLUEMONTE ROSA THERAPEUTICS INC View history and evidence | $26.82M | 2.98% | 1.11M shares | 3.88% → 2.98%-0.90 pp -893.75K (-44.64%) | Reduced | ↗▾ |
| 10 | SNDXSYNDAX PHARMACEUTICALS INC View history and evidence | $26.55M | 2.95% | 1.21M shares | 2.45% → 2.95%+0.50 pp +325.40K (+36.60%) | Added | ↗▾ |
Options overlay 8
$63.64M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
ARKGARK GENOMIC REVOLUTION ETFPUT View history and evidence | Put | 500.00K | $21.03M | +500.00K | ▾ |
SNDXSYNDAX PHARMACEUTICALS INCCALL View history and evidence | Call | 693.60K | $15.16M | +373.60K (+116.75%) | ▾ |
ORICORIC PHARMACEUTICALS INCCALL View history and evidence | Call | 682.60K | $7.39M | +682.60K | ▾ |
3 / 8 options · preview only
Exited positions 25
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| XBI SS SPDR S&P BIOTECH ETF | Put | -825,000 | -$105.38M | SEC filing ↗ | SEC filing ↗ |
| KALV KALVISTA PHARMACEUTICALS INC | Non-derivative | -2,876,407 | -$57.90M | SEC filing ↗ | SEC filing ↗ |
| NUVL NUVALENT INC-A | Non-derivative | -354,914 | -$36.36M | SEC filing ↗ | SEC filing ↗ |
3 / 25 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1816307 · Period Jun 30, 2026
Data loaded Sep 23, 2026 · First reported Aug 13, 2026
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 962154050
}Research all 73 reported holdings.
This page includes 30 of 73 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 73 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_institutional_holdings
{"action":"portfolio","cik":"1816307","quarter":"2026Q2","page_size":100}
akkru_institutional_holdings
{"action":"history","cik":"1816307","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.